Lunit and Agilent Partner to Develop AI-Powered Companion Diagnostics
The collaboration combines Lunit’s AI expertise with Agilent’s diagnostic leadership to improve biomarker testing and enhance precision medicine capabilities.
Read MorePosted by CLP Edit Staff | Sep 24, 2025 | Molecular Diagnostic Analyzers |
The collaboration combines Lunit’s AI expertise with Agilent’s diagnostic leadership to improve biomarker testing and enhance precision medicine capabilities.
Read MorePosted by CLP Edit Staff | Sep 23, 2025 | Leukemia |
The breakapart probe detects gene rearrangements in acute leukemia patients to identify candidates for menin inhibitor therapy.
Read MorePosted by CLP Edit Staff | Sep 22, 2025 | Lung Cancer |
Haystack Oncology and Rutgers Cancer Institute collaborate on phase II trial examining minimal residual disease testing in stage II/III NSCLC patients.
Read MorePosted by CLP Edit Staff | Sep 22, 2025 | Sepsis |
Washington University researchers are developing a rapid test to classify sepsis patients into inflammatory profiles for targeted treatment.
Read MorePosted by Alyx Arnett | Sep 19, 2025 | Allergy & Autoimmune |
From rising demand for comprehensive IgE profiles to the emergence of molecular allergen diagnostics, laboratories are central to how clinicians prepare for and manage September’s asthma spike.
Read More